{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:08:07Z","timestamp":1790374087098,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.vaccine.2005.03.005","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T12:06:54Z","timestamp":1112962014000},"page":"3876-3886","source":"Crossref","is-referenced-by-count":183,"title":["Consequence or coincidence?"],"prefix":"10.1016","volume":"23","author":[{"given":"Ami","family":"Schattner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.03.005_bib1","series-title":"Textbook of the autoimmune diseases","year":"2000"},{"key":"10.1016\/j.vaccine.2005.03.005_bib2","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.molimm.2003.11.011","article-title":"The elusive case for a role of mimicry in autoimmune diseases","volume":"40","author":"Fourneau","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/clinids\/12.2.204","article-title":"Virus-induced autoimmunity","volume":"12","author":"Schattner","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.005_bib5","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1001\/jama.288.24.3155","article-title":"Current controversies in vaccination. Vaccine safety","volume":"288","author":"Maldonaldo","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib6","doi-asserted-by":"crossref","unstructured":"Proceedings of the International Symposium: autoimmunity induced by infection or immunization. J Autoimmunity 2001;16.","DOI":"10.1006\/jaut.2000.0483"},{"key":"10.1016\/j.vaccine.2005.03.005_bib7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.005_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJM199902253400810","article-title":"The case for routine childhood vaccination against hepatitis A","volume":"340","author":"Koff","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/jaut.2000.0502","article-title":"Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis","volume":"16","author":"Trepo","year":"2001","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.vaccine.2005.03.005_bib10","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1542\/peds.105.6.e81","article-title":"Prolonged hepatitis B surface antigenemia after vaccination","volume":"105","author":"Lunn","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.005_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jmv.10509","article-title":"Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection","volume":"71","author":"Ren","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.2003.02093.x","article-title":"The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates","volume":"131","author":"Jafarzadeh","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/infdis\/169.4.807","article-title":"MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon","volume":"169","author":"Roers","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.005_bib14","first-page":"1687","article-title":"The development of Rheumatoid arthritis after recombinant hepatitis B vaccination","volume":"25","author":"Pope","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/38.10.978","article-title":"Rheumatic disorders developed after hepatitis B vaccination","volume":"38","author":"Maillefert","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2005.03.005_bib16","first-page":"191","article-title":"Suspected hepatitis B vaccination related vasculitis","volume":"26","author":"Le Hello","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib17","first-page":"81","article-title":"Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like eruption","volume":"18","author":"De Keyser","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib18","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/1529-0131(200009)43:9<2139::AID-ANR27>3.0.CO;2-3","article-title":"Sjogren's syndrome occurring after hepatitis B vaccination","volume":"43","author":"Toussirot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2005.03.005_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.301.6747.345","article-title":"Hepatitis B vaccine associated with erythema nodosum and polyarthritis","volume":"301","author":"Rogerson","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.03.005_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.53.2.396","article-title":"Encephalitis after hepatitis B vaccination. Recurrent disseminated encephalitis or MS?","volume":"53","author":"Tourbah","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2005.03.005_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/oxfordjournals.aje.a114808","article-title":"Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years","volume":"127","author":"Shaw","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1529-8027.2002.02010.x","article-title":"Postvaccinal inflammatory neuropathy: peripheral nerve biopsies in 3 cases","volume":"7","author":"Vital","year":"2002","journal-title":"J Periph Nerve Syst"},{"key":"10.1016\/j.vaccine.2005.03.005_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/003655498750003465","article-title":"Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases","volume":"30","author":"Neau","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.005_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.7326\/0003-4819-134-12-200106190-00030","article-title":"Immunologic reactions and hepatitis B vaccine","volume":"134","author":"Geier","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.281.5377.630","article-title":"A shadow falls on hepatitis B vaccination effort","volume":"281","author":"Marshall","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.03.005_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis","volume":"344","author":"Confavreux","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib29","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/diacare.22.10.1694","article-title":"Lack of association between early childhood immunizations and \u03b2-cell autoimmunity","volume":"22","author":"Graves","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vaccine.2005.03.005_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jech.52.10.674","article-title":"No evidence that vaccines cause insulin dependent diabetes mellitus","volume":"52","author":"Jefferson","year":"1998","journal-title":"J. Epidemiol. Commun. Health"},{"key":"10.1016\/j.vaccine.2005.03.005_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/12376","article-title":"No increase in demyelinating diseases after hepatitis B vaccination","volume":"5","author":"Zipp","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(99)02991-8","article-title":"School-based hepatitis B vaccination programme and adolescent multiple sclerosis","volume":"355","author":"Sadovnick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.005_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jech.52.10.674","article-title":"No evidence that vaccines cause insulin dependent diabetes mellitus","volume":"52","author":"Jefferson","year":"1998","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.vaccine.2005.03.005_bib34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/BF00400810","article-title":"Decline of mumps antibodies in type 1 diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps\u2013measles\u2013rubella vaccine in Finland. Childhood Diabetes in Finland Study Group","volume":"36","author":"Hyoty","year":"1993","journal-title":"Diabetologica"},{"key":"10.1016\/j.vaccine.2005.03.005_bib35","doi-asserted-by":"crossref","first-page":"E112","DOI":"10.1542\/peds.108.6.e112","article-title":"Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus","volume":"108","author":"DeStefano","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.005_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0895-4356(02)00429-8","article-title":"Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history","volume":"55","author":"Cooper","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14740338.2.3.225","article-title":"Safety of immunization and adverse events following vaccination against hepatitis B","volume":"2","author":"Duclos","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.vaccine.2005.03.005_bib38","series-title":"Cecil textbook of medicine","first-page":"2149","article-title":"Central nervous system complications of viral infections and vaccines","author":"Rudick","year":"2000"},{"key":"10.1016\/j.vaccine.2005.03.005_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00019052-199908000-00005","article-title":"Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis","volume":"12","author":"Stuve","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0733-8619(03)00007-0","article-title":"Childhood autoimmune neurologic diseases of the central nervous system","volume":"21","author":"Jones","year":"2003","journal-title":"Neurol Clin"},{"key":"10.1016\/j.vaccine.2005.03.005_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(87)93051-0","article-title":"Persistent measles virus genome in autoimmune chronic active hepatitis","volume":"2","author":"Robertson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.005_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.62.4.567","article-title":"Thrombocytopenic purpura related to rubella infection","volume":"62","author":"Ozsoyla","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.005_bib43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM198510313131803","article-title":"Persistent rubella virus infection associated with chronic arthritis in children","volume":"313","author":"Chantler","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/dmrr.337","article-title":"A new look at viruses in type 1 diabetes","volume":"19","author":"Jun","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.vaccine.2005.03.005_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.110.5.957","article-title":"Neurologic disorders after measles\u2013mumps\u2013rubella vaccination","volume":"110","author":"Makela","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.005_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(96)07408-9","article-title":"Measles vaccination and Guillain\u2013Barre syndrome","volume":"349","author":"da-Silveira","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.005_bib47","first-page":"27","article-title":"Adverse events following immunization associated with the 1998 Australian Measles Control Campaign","volume":"17","author":"D'Souza","year":"2000","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2005.03.005_bib48","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.005_bib49","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles\u2013mumps\u2013rubella vaccine: implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","article-title":"Aseptic meningitis as a complication of mumps vaccination","volume":"10","author":"Sugiura","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.03.005_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1651-2227.1993.tb12657.x","article-title":"Acute thrombo-cytopenic purpura following measles, mumps, and rubella vaccination. A report on 23 patients","volume":"82","author":"Nieminen","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2005.03.005_bib52","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.271.20.1602","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM196512162732504","article-title":"Purpura in congenital and acquired rubella","volume":"273","author":"Bayer","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/152.3.606","article-title":"Postpartum rubella immunization: association with development of prolonged arthritis, neurologic sequelae, and chronic rubella viremia","volume":"152","author":"Tingle","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.005_bib55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/jama.267.3.392","article-title":"Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine","volume":"267","author":"Howson","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib56","first-page":"767","article-title":"A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database","volume":"20","author":"Geier","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib57","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0264-410X(95)00096-J","article-title":"Absence of an association between rubella vaccination and arthritis in underimmune postpartum women","volume":"13","author":"Slater","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.03.005_bib58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.278.7.551","article-title":"Risk of chronic arthropathy among women after rubella vaccination","volume":"278","author":"Ray","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib59","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","article-title":"Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis","volume":"322","author":"Kaye","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.03.005_bib60","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/diacare.23.7.969","article-title":"No major association of breast feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB study","volume":"23","author":"Hummel","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vaccine.2005.03.005_bib61","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpedi.155.3.354","article-title":"Measles\u2013mumps\u2013rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project","volume":"155","author":"Davis","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schoenberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib63","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.aje.a115973","article-title":"Reassessment of the association between Guillain\u2013Barre syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group","volume":"133","author":"Safranek","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib64","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","article-title":"Influenza vaccination and Guillain Barre syndrome small star, filled","volume":"107","author":"Geier","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1600-0404.1982.tb06864.x","article-title":"Neurological complications of swine influenza vaccination","volume":"66","author":"Poser","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.vaccine.2005.03.005_bib67","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/bmj.2.5914.331-d","article-title":"Polyarteritis after influenza vaccination","volume":"2","author":"Wharton","year":"1974","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.03.005_bib69","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archinte.140.6.847","article-title":"A possible association between influenza vaccination and small-vessel vasculitis","volume":"140","author":"Blumberg","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib70","first-page":"1198","article-title":"Microscopic polyangiitis after influenza vaccination","volume":"24","author":"Kelsall","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib71","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/archinte.160.17.2677","article-title":"Giant cell arteritis after influenza vaccination","volume":"160","author":"Perez","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib72","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1445-5994.1994.tb01760.x","article-title":"Rheumatic complications of influenza vaccination","volume":"24","author":"Brown","year":"1994","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib73","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of infections in Guillain\u2013Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2005.03.005_bib74","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.aje.a009369","article-title":"Nationwide oral poliovirus vaccination campaign and the incidence of Guillain\u2013Barre syndrome","volume":"147","author":"Kinnunen","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib76","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(94)70307-8","article-title":"Epidemiology of Guillain\u2013Barre in children: relationship of oral poliovaccine administration to occurrence","volume":"124","author":"Rantala","year":"1994","journal-title":"J Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.005_bib77","first-page":"105","article-title":"A case-control study on children with Guillain\u2013Barre syndrome in North China","volume":"16","author":"Liu","year":"2003","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.vaccine.2005.03.005_bib78","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib79","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","article-title":"Postlicensure safety surveillance for varicella vaccine","volume":"284","author":"Wise","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/jaut.2000.0491","article-title":"Epidemiology of autoimmune reactions induced by vaccination","volume":"16","author":"Chen","year":"2001","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.vaccine.2005.03.005_bib81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0022-510X(75)90061-1","article-title":"Neurological complication of antirabies vaccination in Sao Paulo, Brazil. Clinical and therapeutic aspects","volume":"26","author":"Assis","year":"1975","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2005.03.005_bib82","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archneur.1977.00500230064011","article-title":"Neuroparalytic accidents of antirabies vaccination with suckling mouse brain vaccine. Clinical and pathologic study of 21 cases","volume":"34","author":"Toro","year":"1977","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM198702123160703","article-title":"Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination","volume":"316","author":"Hemachudha","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib84","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-510X(90)90127-9","article-title":"Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases","volume":"96","author":"Chaleomchan","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2005.03.005_bib85","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0091-6749(87)80156-2","article-title":"Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine","volume":"79","author":"Warrington","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2002-33052","article-title":"The smallpox vaccine and postvaccinal encephalitis","volume":"22","author":"Roos","year":"2002","journal-title":"Semin Neurol"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2005.03.005_bib87","first-page":"1","article-title":"Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recommend Rep"},{"key":"10.1016\/j.vaccine.2005.03.005_bib88","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-na\u00efve US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib89","first-page":"280","article-title":"Myocardial complications of immunizations","volume":"10","author":"Helle","year":"1978","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.vaccine.2005.03.005_bib90","first-page":"912","article-title":"Compliance with influenza vaccination and the health belief model","volume":"2","author":"Green","year":"2000","journal-title":"IMAJ"},{"key":"10.1016\/j.vaccine.2005.03.005_bib91","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1056\/NEJM200102013440509","article-title":"The risk of vaccination \u2014 the importance of \u201cnegative\u201d studies","volume":"344","author":"Gellin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib92","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1001\/jama.287.24.3245","article-title":"Content and design attributes of antivaccination web sites","volume":"287","author":"Wolfe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.03.005_bib93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0049-0172(99)80024-9","article-title":"Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature","volume":"29","author":"Older","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2005.03.005_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity \u2014 \u2018vaccinosis\u2019: a dangerous liason?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.vaccine.2005.03.005_bib95","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20040358","article-title":"Molecular characterization of virus-induced autoantibody responses","volume":"200","author":"Ludewig","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vaccine.2005.03.005_bib97","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.20463","article-title":"Evidence for coxsackievirus infection in primary Sjogren's syndrome","volume":"50","author":"Triantafyllopoulou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2005.03.005_bib98","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/jaut.2000.0492","article-title":"From infection to autoimmunity","volume":"16","author":"Fairweather","year":"2001","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.vaccine.2005.03.005_bib99","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1172\/JCI200422557","article-title":"A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes","volume":"114","author":"Christen","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2005.03.005_bib100","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2004-01-0310","article-title":"Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses","volume":"104","author":"Musaji","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2005.03.005_bib101","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1128\/JVI.74.13.6045-6049.2000","article-title":"Exacerbation of autoantibody-mediated hemolytic anemia by viral infection","volume":"74","author":"Meite","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1288.003","article-title":"Can enteroviruses cause type 1 diabetes?","volume":"1005","author":"Tauriainen","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2005.03.005_bib103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2005.03.005_bib104","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/nm1097-1133","article-title":"Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading","author":"Miller","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0798-781","article-title":"Diabetes induced by coxackievirus: initiation by bystander damage and not molecular mimicry","volume":"4","author":"Horwitz","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib106","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.279.5355.1344","article-title":"Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection","volume":"279","author":"Zhao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.03.005_bib107","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI200113032","article-title":"A virus-induced molecular mimicry model of multiple sclerosis","volume":"108","author":"Olson","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2005.03.005_bib108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/clin.1994.1027","article-title":"Lymphokines in autoimmunity. Short analytical review","volume":"70","author":"Schattner","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib109","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.vaccine.2005.03.005_bib110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","article-title":"Animal models for autoimmune demyelinating disorders of the nervous system","volume":"6","author":"Gold","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1016\/j.vaccine.2005.03.005_bib111","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2169\/internalmedicine.42.191","article-title":"Neurologic complications associated with influenza vaccination: two adult cases","volume":"42","author":"Nakamura","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib112","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.49.3.748-753.1984","article-title":"Interferon-induced 2\u20135A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines","volume":"49","author":"Penn","year":"1984","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib113","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/322617","article-title":"Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient","volume":"33","author":"Konstantinou","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.005_bib114","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1542\/peds.97.5.738","article-title":"Recurrent thrombocytopenic purpura after repeated measles\u2013mumps\u2013rubella vaccination","volume":"97","author":"Vlacha","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.03.005_bib115","first-page":"749","article-title":"A case-series of adverse events, positive re-challenge of symptoms and events in identical twins following hepatitis B vaccination. Analysis of the VAERS database and literature review","volume":"22","author":"Geier","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib116","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/36.3.366","article-title":"Patients who develop inflammatory polyarthritis (IP) after immunization are clinically indistinguishable from other patients with IP","volume":"36","author":"Harrison","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib117","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJMra011223","article-title":"Vaccines and vaccination","volume":"345","author":"Ada","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib118","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bmj.327.7417.750-b","article-title":"Balancing benefits and harms in health care. Observational data on harm are already included in systematic reviews","volume":"327","author":"Jefferson","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.03.005_bib119","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-88-6-729","article-title":"Influenza immunization in systemic lupus erythematosus. A double-blind trial","volume":"88","author":"Williams","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2005.03.005_bib120","first-page":"1681","article-title":"Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity","volume":"27","author":"Abu-Shakra","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib121","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/ard.47.7.532","article-title":"In vitro response to influenza immunization by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases","volume":"47","author":"Turner-Stokes","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2005.03.005_bib122","first-page":"1203","article-title":"Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity","volume":"21","author":"Chalmers","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2005.03.005_bib123","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","article-title":"A multi-center randomized double-blind placebo controlled trial of influenza immunization in multiple sclerosis","volume":"48","author":"Miller","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2005.03.005_bib124","unstructured":"Update. Vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR-12):1\u201335."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T21:21:44Z","timestamp":1683062504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05003506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":124,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0264410X05003506"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}